Huifeng Bio-Pharma Tech (OTC BB:HFGB)

	Recent 52-week high
	30% Earnings Per Share (EPS) growth rate
	10% revenue growth year over year
	Strong balance sheet
	15% minimum return on equity (ROE)
	8% minimum pre-tax margins
	Under 50 million shares outstanding
	High insider ownership
	Limited institutional ownership
	P/E at least 1/2 of EPS growth rate

Excerpt from GeoWire article.

Huifeng Bio-Pharma Tech (OTC BB:HFGB).  This stock was one of several that was referenced in a past GeoTeam article.  It recently eclipsed its book per share of $0.55 and had a brief stint over $1. HFGB is a diversified pharmaceutical firm. The company recently hired an IR firm, reviving the hope that it may be ready for bigger things.  In fact, on February 4^th, 2010, the company issued 2009 net income guidance around $3 million and 2010 guidance of $4.5 to $5.0 million. The stock currently trades at about a P/E of 6 on 2009 implied EPS guidance of $0.13.